Longevity Peptide Stack Research Reference: Epithalon, MOTS-c, and SS-31

Overview

The convergence of telomere biology, mitochondrial biology, and epigenetic aging research has led to growing interest in combination approaches using peptides that address multiple hallmarks of aging simultaneously. Among the most researched multi-compound longevity protocols is the combination of Epithalon (telomerase activator), MOTS-c (mitochondrial-derived metabolic regulator), and SS-31/Elamipretide (mitochondrial cardiolipin protector). This reference article outlines the rationale for this combination, each compound’s role, and considerations for researchers studying aging biology.

Epithalon: Telomere Biology and Pineal Regulation

Epithalon (Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from Epithalamin, a natural peptide extract of the pineal gland. It is the most studied compound in Vladimir Khavinson’s bioregulator research program. Epithalon has been shown to activate telomerase in somatic cells, extend telomere length, and reset several markers of biological aging in animal studies. Long-term studies (up to 3 years) in elderly cohorts reported in Russian literature document reduced all-cause mortality and cancer incidence in Epithalon-treated groups versus controls. In research contexts, Epithalon is used as a reference compound for studying telomerase activation, melatonin regulation, and epigenetic clock resetting.

MOTS-c: Mitochondrial Metabolism and Exercise Mimicry

MOTS-c (mitochondrial open reading frame of the 12S rRNA-c) is a 16-amino acid mitochondria-derived peptide encoded in the 12S rRNA gene. It regulates metabolic flexibility by activating AMPK and the folate cycle, improving glucose uptake in skeletal muscle, and reducing adipogenesis. MOTS-c levels decline with age and are elevated in response to exercise — leading researchers to describe it as an “exercise mimetic” at the molecular level. In animal models, MOTS-c supplementation improves insulin sensitivity, reverses age-related metabolic decline, extends lifespan, and enhances physical performance. Its role in the longevity stack is to address the metabolic hallmarks of aging: mitochondrial dysfunction and dysregulated nutrient sensing.

SS-31 (Elamipretide): Mitochondrial Membrane Protection

SS-31 (Szeto-Schiller peptide 31, Elamipretide) is a synthetic tetrapeptide that selectively concentrates in the inner mitochondrial membrane (IMM), where it binds cardiolipin — a phospholipid critical for cristae architecture, electron transport chain function, and ATP synthase activity. Age-related cardiolipin oxidation destabilizes the IMM and impairs mitochondrial efficiency. SS-31 protects cardiolipin from oxidative damage, restores cristae structure, and improves ATP production in aged mitochondria. In animal models, SS-31 reverses age-related cardiac dysfunction, skeletal muscle weakness, and kidney disease. Phase 2 human trials in heart failure with preserved ejection fraction (HFpEF) and Barth syndrome have demonstrated safety and preliminary efficacy signals.

Combination Rationale

The three compounds address complementary biological targets: Epithalon targets nuclear aging (telomeres, epigenetic clock); MOTS-c targets cytoplasmic and metabolic aging (AMPK, insulin sensitivity, mitochondrial biogenesis signaling); SS-31 targets inner mitochondrial membrane integrity (cardiolipin, electron transport chain efficiency). Together they represent a multilevel approach to the mitochondrial-nuclear aging axis. Research protocols typically involve each compound administered separately with appropriate intervals, as combination pharmacokinetics and potential interactions require independent investigation.

Research Use Only

Epithalon, MOTS-c, and SS-31 are available from FenaLife for laboratory research use only. Not for human or veterinary use. Certificate of Analysis available per batch.